Kameyama K

No ORCID on file · 4 papers in corpus · active 2009-2020

Study types

  • article 1
  • other 1

Condition tags

  • endometriosis 2
2020
Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing.
Scientific reports ·doi:10.1038/s41598-020-69488-9

The use of primary patient-derived organoids for drug sensitivity and resistance testing could play an important role in precision cancer medicine. We developed expandable ovarian cancer organoids in < 3 weeks; these organoids captured the …

other 2018
Differentiation of Seromucinous Borderline Tumor from Serous Borderline Tumor on MR Imaging
Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine ·doi:10.2463/mrms.mp.2017-0055

PURPOSE: Seromucinous borderline tumor (SMBT) is a newly categorized ovarian tumor in the 2014 revised World Health Organization (WHO) classification. SMBT is similar to serous borderline tumor (SBT) on MRI reflecting their pathological fin…

article 2016
Diagnostic performance of MR imaging findings and quantitative values in the differentiation of seromucinous borderline tumour from endometriosis-related malignant ovarian tumour
European radiology ·doi:10.1007/s00330-016-4533-x

ObjectivesTo evaluate the diagnostic performance of quantitative values and MRI findings for differentiating seromucinous borderline tumours (SMBTs) from endometriosis-related malignant ovarian tumours (MT).MethodsThis retrospective study e…

2009
Primary intratesticular leiomyosarcoma.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada ·doi:10.5489/cuaj.1184

This report presents a case of primary intratesticular leiomyosarcoma. A 73-year-old male presented with a 6-year history of left scrotal swelling. A radiological examination revealed a left testicular tumour with multiple metastases in the…